Tang W - Search Results

1

metaProbiotics: a tool for mining probiotic from metagenomic binning data based on a language model.

Wu S, Feng T, Tang W, Qi C, Gao J, He X, Wang J, Zhou H, Fang Z. Wu S, et al. Among authors: tang w. Brief Bioinform. 2024 Jan 22;25(2):bbae085. doi: 10.1093/bib/bbae085. Brief Bioinform. 2024. PMID: 38487846 Free PMC article.

2

Polyphenol-Rich Liupao Tea Extract Prevents High-Fat Diet-Induced MAFLD by Modulating the Gut Microbiota.

Tang W, Yuan M, Li Z, Lin Q, Zhen Y, Li Z, Zhou H, Xia F. Tang W, et al. Nutrients. 2022 Nov 21;14(22):4930. doi: 10.3390/nu14224930. Nutrients. 2022. PMID: 36432617 Free PMC article.

3

Ultrasonic effects on the degradation kinetics, structural characteristics and protective effects on hepatocyte lipotoxicity induced by palmitic acid of Pueraria Lobata polysaccharides.

Dou Z, Zhang Y, Tang W, Deng Q, Hu B, Chen X, Niu H, Wang W, Li Z, Zhou H, Zeng N. Dou Z, et al. Among authors: tang w. Ultrason Sonochem. 2023 Dec;101:106652. doi: 10.1016/j.ultsonch.2023.106652. Epub 2023 Oct 17. Ultrason Sonochem. 2023. PMID: 37865008 Free PMC article.

4

Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury.

Xia F, Yao X, Tang W, Xiao C, Yang M, Zhou B. Xia F, et al. Among authors: tang w. Front Pharmacol. 2017 Feb 28;8:99. doi: 10.3389/fphar.2017.00099. eCollection 2017. Front Pharmacol. 2017. PMID: 28293193 Free PMC article.

5

Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.

Tang W, Yao X, Xia F, Yang M, Chen Z, Zhou B, Liu Q. Tang W, et al. Oxid Med Cell Longev. 2018 Dec 23;2018:7261619. doi: 10.1155/2018/7261619. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30671174 Free PMC article.

6

Data for iTRAQ-based quantification of the effect of HuganQingzhi on non-alcoholic fatty liver disease in rats.

Yao X, Xia F, Tang W, Xiao C, Yang M, Zhou B. Yao X, et al. Among authors: tang w. Data Brief. 2017 Oct 16;15:612-614. doi: 10.1016/j.dib.2017.10.027. eCollection 2017 Dec. Data Brief. 2017. PMID: 29085877 Free PMC article.

7

[Establishment of a L-02 cell model of hepatic steatosis].

Yin J, Tang W, Zeng L, Zhou B. Yin J, et al. Among authors: tang w. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jun;34(6):837-42. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24968841 Chinese.

8

[Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].

Yao XR, Xia F, Tang WJ, Zhou BJ. Yao XR, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2017 Jan 20;37(1):56-62. doi: 10.3969/j.issn.1673-4254.2017.01.10. Nan Fang Yi Ke Da Xue Xue Bao. 2017. PMID: 28109099 Free PMC article. Chinese.

9

Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.

Yang M, Yao X, Xia F, Xiang S, Tang W, Zhou B. Yang M, et al. Among authors: tang w. BMC Complement Med Ther. 2024 Jan 12;24(1):36. doi: 10.1186/s12906-024-04336-1. BMC Complement Med Ther. 2024. PMID: 38216941 Free PMC article.

10

Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ.

Yang M, Chen Z, Xiang S, Xia F, Tang W, Yao X, Zhou B. Yang M, et al. Among authors: tang w. BMC Complement Med Ther. 2020 Dec 11;20(1):377. doi: 10.1186/s12906-020-03164-3. BMC Complement Med Ther. 2020. PMID: 33308192 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,067 results

Search Page

Filters